Pseudomonas aeruginosaBacteremic Patients Exhibit Nonprotective Antibody Titers Against Therapeutic Antibody Targets PcrV and Psl Exopolysaccharide

A Novel Anti-PcrV Antibody Providing Enhanced Protection against Pseudomonas aeruginosa in Multiple Animal Infection Models

(2014) Paul Warrener et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Predictive values of antibodies against Pseudomonas aeruginosa in patients with cystic fibrosis one year after early eradication treatment

(2014) Matthias Kappler et al.   Journal of Cystic Fibrosis

A multifunctional bispecific antibody protects against Pseudomonas aeruginosa

(2014) A. DiGiandomenico et al.   Science Translational Medicine

Epitope Mapping of Monoclonal Antibodies using Synthetic Oligosaccharides Uncovers Novel Aspects of Immune Recognition of the Psl Exopolysaccharide ofPseudomonas aeruginosa

(2013) Huiqing Li et al.   CHEMISTRY-A EUROPEAN JOURNAL

Psl trails guide exploration and microcolony formation in Pseudomonas aeruginosa biofilms

(2013) Kun Zhao et al.   NATURE

Anti-PcrV antibody in cystic fibrosis: A novel approach targetingPseudomonas aeruginosaairway infection

(2013) Carlos E. Milla et al.   PEDIATRIC PULMONOLOGY

Type III Secretion of ExoU Is Critical during Early Pseudomonas aeruginosa Pneumonia

(2013) H. A. Howell et al.   mBio

Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa

(2012) Bruno François et al.   CRITICAL CARE MEDICINE

Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trial

(2012) Michael Anstead et al.   Journal of Cystic Fibrosis

Identification of broadly protective human antibodies toPseudomonas aeruginosaexopolysaccharide Psl by phenotypic screening

(2012) Antonio DiGiandomenico et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization

(2011) Meenu Mishra et al.   CELLULAR MICROBIOLOGY

Key two-component regulatory systems that control biofilm formation in Pseudomonas aeruginosa

(2011) Helga Mikkelsen et al.   ENVIRONMENTAL MICROBIOLOGY

PcrV antibody–antibiotic combination improves survival in Pseudomonas aeruginosa-infected mice

(2011) Y. Song et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Biosynthesis of the Pseudomonas aeruginosa Extracellular Polysaccharides, Alginate, Pel, and Psl

(2011) Michael J. Franklin et al.   Frontiers in Microbiology

Polymorphisms in the Pseudomonas aeruginosa type III secretion protein, PcrV – Implications for anti-PcrV immunotherapy

(2010) Susan V. Lynch et al.   MICROBIAL PATHOGENESIS

Genetic and biochemical analyses of thePseudomonas aeruginosaPsl exopolysaccharide reveal overlapping roles for polysaccharide synthesis enzymes in Psl and LPS production

(2009) Matthew S. Byrd et al.   MOLECULAR MICROBIOLOGY

Antibody response toPseudomonas aeruginosain children with cystic fibrosis

(2009) Lucimar G. Milagres et al.   PEDIATRIC PULMONOLOGY

An Engineered Human Antibody Fab Fragment Specific for Pseudomonas aeruginosa PcrV Antigen Has Potent Antibacterial Activity

(2008) M. Baer et al.   INFECTION AND IMMUNITY